BIS-F logo

Bioscience Animal Health THAMSE:BIS-F Stock Report

Last Price

฿6.00

Market Cap

฿979.7m

7D

0%

1Y

0%

Updated

28 Dec, 2024

Data

Company Financials

Bioscience Animal Health Public Company Limited

THAMSE:BIS-F Stock Report

Market Cap: ฿979.7m

BIS-F Stock Overview

Manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand. More details

BIS-F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends2/6

Rewards

Price-To-Earnings ratio (15.6x) is below the Healthcare industry average (21.7x)

Earnings grew by 31.6% over the past year

Risk Analysis

Does not have a meaningful market cap (THB980M)

Dividend of 3.85% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Bioscience Animal Health Public Company Limited Competitors

Winnergy Medical

SET:WINMED

฿724.0m

SEI Medical

SET:SEI

฿683.4m

SaintMed

SET:SMD100

฿951.3m

Business Alignment

SET:BIZ

฿2.1b

Price History & Performance

Summary of share price highs, lows and changes for Bioscience Animal Health
Historical stock prices
Current Share Price฿6.00
52 Week High฿0
52 Week Low฿0
Beta0.81
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

BIS-FTH HealthcareTH Market
7D0%2.9%2.7%
1Y0%-16.6%-1.6%

Return vs Industry: BIS-F exceeded the TH Healthcare industry which returned -16.6% over the past year.

Return vs Market: BIS-F exceeded the TH Market which returned -1.6% over the past year.

Price Volatility

Is BIS-F's price volatile compared to industry and market?
BIS-F volatility
BIS-F Average Weekly Movement0%
Healthcare Industry Average Movement4.0%
Market Average Movement4.3%
10% most volatile stocks in TH Market8.8%
10% least volatile stocks in TH Market2.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine BIS-F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aDhanawat Khongjaroensombatwww.bis-group.com/en/our-subsidiaries/bioscience-animal-health

Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services.

Bioscience Animal Health Public Company Limited Fundamentals Summary

How do Bioscience Animal Health's earnings and revenue compare to its market cap?
BIS-F fundamental statistics
Market cap฿979.68m
Earnings (TTM)฿62.67m
Revenue (TTM)฿2.39b

15.6x

P/E Ratio

0.4x

P/S Ratio

Is BIS-F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIS-F income statement (TTM)
Revenue฿2.39b
Cost of Revenue฿2.03b
Gross Profit฿358.56m
Other Expenses฿295.90m
Earnings฿62.67m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.20
Gross Margin14.98%
Net Profit Margin2.62%
Debt/Equity Ratio0.8%

How did BIS-F perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

60%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 22:42
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioscience Animal Health Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution